Supernus Pharmaceuticals announced that its management will participate in two major healthcare investor conferences in June 2026: the Jefferies Global Healthcare Conference on June 3 in New York and the Goldman Sachs 47th Annual Global Healthcare Conference on June 8 in Miami Beach. The company, which develops treatments for central nervous system diseases, will webcast its Jefferies conference session live and provide archived replays. These events offer investors a chance to hear directly from the company’s leadership about its ongoing projects and future outlook in the CNS treatment market.
AIX Alpha has introduced a new AI-powered automated trading platform designed to help retail traders manage the increasing volatility in digital asset markets, particularly XRP. The system analyzes over 100,000 market signals daily and adjusts strate...
SpaceX is preparing for the largest IPO in history with its Starlink satellite network, targeting a valuation between $1.75 trillion and $2 trillion. This IPO will surpass previous tech giants' offerings by a huge margin and highlights the rapid grow...
XRP's recent price recovery is driven by the liquidation of most major leveraged long positions accumulated in May, which has cleaned the market structure and removed downside liquidity traps. Technical indicators like MACD and RSI are turning bullis...
Pfizer is navigating a transitional phase aiming for growth by 2029, maintaining its dividend payout to support financial stability despite patent losses and reduced COVID revenues. The company’s dividend payout ratio aligns with management’s long-te...
Crypto analyst Crypto Patel outlines a three-phase growth plan for Litecoin, starting with reclaiming $100-$140 by 2027, then $200-$280 after the 2027 halving, and potentially reaching $500-$700 in the next bull cycle. A $1,000 target is possible but...
